deoxycholic-acid and Hypertrophy

Botulinum toxin type A can produce dramatic improvements in patients with benign masseteric hypertrophy but this method alone is not as effective for patients with a rounded lower face. The paper describes the effective use of selective lower jowl phosphatidylcholine/deoxycholate lipolysis and chin, cheek, and nose augmentation with hyaluronic acid to refine cosmetic lower facial contouring using botulinum toxin type A in a young Asian woman. A series of treatments was administered over 26 months. The patient's lower cheeks were slimmed and jowl definition was improved producing the patient's desired sculptured, heart-shaped face. The injection-based procedures provided much preferable alternative to surgery from the perspective of both the patient and her family. The authors believe that this is the first case report in the published literature reporting these three methods used in conjunction.

Topics: Adult; Botulinum Toxins, Type A; Cosmetic Techniques; Deoxycholic Acid; Female; Humans; Hyaluronic Acid; Hypertrophy; Lipolysis; Masseter Muscle; Neuromuscular Agents; Phosphatidylcholines; Viscosupplements; Young Adult

Total and free ribosomes were isolated from postnuclear supernatants of trypsinized normal and 3-methylcholanthrene-treated epidermis from female CD-1 mice. Membrane-bound ribosomes were determined as the calculated difference between total and free ribosomes. The value for total ribosomes from normal epidermis in the resting phase of the hair growth cycle was 0.32 mg. of ribosomal RNA per gm. of epidermis, or 0.07 mg. of ribosomal RNA per mg. of homogenate DNA. About 96 per cent of the ribosomes were free and 4 per cent were membrane-bound. Five days after a single application of 2 mu moles of 3-methylcholanthrene to the dorsal skin in the resting phase of the hair growth cycle, there was epidermal hyperplasia and cellular hypertrophy. Total ribosomes increased 2- to 3-fold, to 0.80 mg. of ribosomal RNA per gm. of epidermis, or 0.21 mg. of ribosomal RNA per mg. of homogenate DNA. This increase was further characterized as proportionate increases of both free and membrane-bound ribosomes.

Topics: Animals; Biopsy; Buffers; Cell Membrane; Deoxycholic Acid; DNA; Female; Hair; Hyperplasia; Hypertrophy; Liver; Methylcholanthrene; Mice; Polyethylene Glycols; Potassium Chloride; Ribosomes; RNA, Ribosomal; Skin; Subcellular Fractions; Trypsin

Killed vaccines, deoxycholate-extracted or heated, were shown to induce an effective degree of immunity which protected against death (100%), prevented extensive multiplication, and left the mice with low residual salmonella populations in spleen and liver after intravenous (iv) or intraperitoneal (ip) challenge with virulent Salmonella typhimurium. Protection was most effective against the ip challenge route and less effective against the iv route. A study of the kinetics of the population of bacteria in the spleens and livers of immunized animals showed that after ip challenge there was an initial reduction of 99% at 6 hr after challenge, maintenance of levels of less than 10(3) bacteria per organ, and a final population of 10(2) to 10(3) per organ at 21 days. With iv challenge, after an initial reduction of 90% at 6 hr, growth ensued to levels above 10(6) bacteria per organ until 8 days, followed by a steady decline yielding residual populations of 10(3) to 10(4) in some cases. Organ hypertrophy correlated with bacterial population. Morbidity was prevented (as measured by gain in body weight) by immunization against ip challenge but not against iv challenge. Killed vaccines protected by their ability to induce an immune state which reduced the initial challenge population, prevented extensive multiplication, yet allowed "cellular immunity" to develop due to response to the living challenge infection itself. The consequence was a low-level carrier state similar to that induced by recovery from sublethal virulent infection.

Topics: Animals; Bacterial Vaccines; Body Weight; Deoxycholic Acid; Female; Hypertrophy; Immunity, Cellular; Immunization; Injections, Intraperitoneal; Injections, Intravenous; Kinetics; Lethal Dose 50; Liver; Mice; Organ Size; Salmonella Infections; Salmonella typhimurium; Spleen; Time Factors